InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
InMed Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: October 28, 2022
InMed Pharmaceuticals reported fiscal year 2021 executive compensation information on October 28, 2022.
In 2021, four executives at InMed Pharmaceuticals received on average a compensation package of $514K, a 33% increase compared to previous year.
Average pay of disclosed executives at InMed Pharmaceuticals
Eric A. Adams, Chief Executive Officer, received $735K in total, which increased by 73% compared to 2020. 45% of Adams' compensation, or $328K, was in salary. Adams also received $161K in bonus and $247K in option awards.
Bruce Colwill, Chief Financial Officer, received a compensation package of $516K, which increased by 20% compared to previous year. 53% of the compensation package, or $274K, was in salary.
Alexandra Mancini, Senior VP, Clinical & Regulatory Affairs, earned $406K in 2021, a 32% increase compared to previous year.
Eric Hsu, Senior Vice President, PreClinical R&D, received $398K in 2021.
InMed Pharmaceuticals' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 28, 2022.